Related Experiment Video
Updated: Jul 30, 2025
08:36
Collecting Sleep, Circadian, Fatigue, and Performance Data in Complex Operational Environments
Published on: August 8, 2019
12.1K
Novel Objective Measures of Hypersomnolence
Alex Dworetz1, Lynn Marie Trotti2,3, Surina Sharma2,4
1Sleep Disorders Center, Atlanta Veterans Affairs Medical Center, Atlanta, GA.
Current Sleep Medicine Reports
|May 16, 2023
Summary
Objective measures for hypersomnolence are evolving. Novel metrics like quantitative EEG and cognitive testing show promise for improving diagnosis of central disorders of hypersomnolence (CDH).
Area of Science:
- Neurology
- Sleep Medicine
- Diagnostic Tools
Background:
- Hypersomnolence disorders present diagnostic challenges.
- Current objective measures require optimization for improved diagnostic precision.
Purpose of the Study:
- To review current objective measures for hypersomnolence.
- To discuss modifications to existing tools.
- To explore emerging measurement techniques.
Main Methods:
- Review of current literature on objective measures of hypersomnolence.
- Discussion of novel metrics including quantitative EEG, cognitive testing, neuroimaging, and pupillometry.
- Analysis of proposed modifications and emerging technologies.
Main Results:
- High-density and quantitative EEG offer discriminative information.
- Cognitive testing can quantify attention deficits and sleep inertia.
- Neuroimaging implicates hypothalamic and extra-hypothalamic regions in narcolepsy type 1.
- Pupillometry shows renewed interest for alertness assessment.
Conclusions:
- No single measure is sufficient for diagnosing the full spectrum of hypersomnolence disorders.
- Combining multiple measures is likely to enhance diagnostic accuracy.
- Further research is needed for novel biomarkers and optimal diagnostic combinations for central disorders of hypersomnolence (CDH).
More Related Videos
Related Concept Videos
01:19Management of Insomnia
289
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
289
01:24Substance Use Disorders Affecting Sleep
201
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
201
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
206
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
206
01:24Sleep-Wake Cycles
1.4K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.4K
01:07Narcolepsy
160
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
160
01:27Insomnia
111
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
111